Gel Use Disclosure in an Open-label 1% Tenofovir Gel Trial: Perspectives from Participants, Partners and Community Men in KwaZulu-Natal, South Africa
2014 ◽
Vol 30
(S1)
◽
pp. A10-A10
Keyword(s):
2014 ◽
Vol 30
(S1)
◽
pp. A282-A282
Keyword(s):
2017 ◽
Vol 26
(2)
◽
pp. 124-140
◽
Keyword(s):
Keyword(s):